Merck & Co Inc

NYSE: MRK
$126.45
+$0.60 (+0.5%)
Closing Price on July 5, 2024

MRK Chart and Intraday Price

MRK Company Data

Asset Type Stock
Exchange NYSE
Currency USD
Country USA
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 2000 GALLOPING HILL ROAD, KENILWORTH, NJ, US
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 321,543.96M USD
Shares Outstanding 2,532,640,000
Merck & Co Inc is a global healthcare leader known for its innovative pharmaceuticals and animal health products. With a rich history dating back to 1891, Merck has made significant strides in oncology, immunology, neuroscience, and more, offering well-known brands like Keytruda and Januvia. Its pharmaceutical segment focuses on human health, while the Animal Health division provides veterinary pharmaceuticals and services. Merck collaborates with industry giants like AstraZeneca and Bayer, emphasizing its commitment to advancing healthcare across both human and animal sectors.

MRK Articles

Wall Street expectations for where Eli Lilly stock is headed this year vary considerably, but some analysts still have faith.
24/7 Insights Quality dividend stocks outperform non-dividend stocks for shareholders. Dividend stocks can deliver dependable passive income streams. Access 2 legendary, high-yield dividend stocks...
24/7 Wall Street Insights With inflation showing few signs of appreciable reversal, prices for other goods and services will inevitably continue to rise. Among the passive income options available to...
24/7 Insights The Nasdaq is up a stunning 14.5% this year after a massive 43% gain in 2023. Nasdaq dividend stocks are still reasonably priced, including Cisco Systems Inc. (NASDAQ: CSCO). Unloved...
It defies all reason that elected officials are allowed to buy and sell stock in an economy that they are actively involved in running and are in charge of making the laws for, yet they are among the...
24/7 Insights AI stocks are facing headwinds and sky high valuations are cooling down J.P. Morgan’s top picks are in May are stable, established brands 2 legendary, high-yield dividend stocks Wall...
Private healthcare sure does seem to be working well in America, doesn’t it? With skyrocketing healthcare costs with diminishing returns, a lower life expectancy, unofficial waitlists, and absurdly...
On the cover of the Friday, April 12, 2024 edition of The Wall Street Journal, the headline read: “Cost of Owning a Home Soars”. The article cited one family whose home insurance costs had risen...
Investors love dividend stocks because they provide dependable income and a great opportunity for solid total return. Total return includes interest, capital gains, dividends, and distributions...
Every year, the top Wall Street firms release a list of their top stock picks for the coming 12 months, and typically, they are companies that the stock analysts have incredibly high conviction in....
Here is an assessment of how safe the dividend at AbbVie appears to be based on a variety of metrics, including its status as a Dividend Aristocrat.
Fourth-quarter earnings kick off in a big way in 7 to 10 days, and earnings at some of the biggest and best U.S. companies are likely expected to decline for the third quarter running. Many top...
While many investment professionals suggest short Treasury paper and money markets, healthcare is the place in 2024 for long-term investors looking for growth and income. Demand is growing as the...
This year’s Artificial Intelligence rally led by the so-called “Magnificent 7” has been fantastic if you owned those stocks. The reality is the great bulk of the S&P 500 is treading water for...
If any investor has stood the test of time, it’s Warren Buffett, and with good reason. For years, the “Oracle of Omaha” has had a rock star-like presence in the investing world, and his annual...